Outcomes after escalation of infliximab therapy in ambulatory patients with moderately active ulcerative colitis-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Outcomes after escalation of infliximab therapy in ambulatory patients with moderately active ulcerative colitis

Published:2012-01-13 Issue:5 Volume:35 Page:562-567
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Rostholder E.¹,Ahmed A.¹,Cheifetz A. S.¹,Moss A. C¹

Affiliation:

1. Center for Inflammatory Bowel Disease; Beth Israel Deaconess Medical Center; Harvard Medical School; Boston; MA; USA

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2036.2011.04986.x/fullpdf

Reference28 articles.

1. Steroid-refractory severe ulcerative colitis: what are the available treatment options?;Moss;Drugs,2008

2. Treatment of ulcerative colitis with adalimumab or infliximab: long-term follow-up of a single-centre cohort;Gies;Aliment Pharmacol Ther,2010

3. Systematic review: infliximab therapy in ulcerative colitis;Gisbert;Aliment Pharmacol Ther,2007

4. A multicenter experience with infliximab for ulcerative colitis: outcomes and predictors of response, optimization, colectomy, and hospitalization;Oussalah;Am J Gastroenterol,2010

5. Infliximab for induction and maintenance therapy for ulcerative colitis;Rutgeerts;N Engl J Med,2005

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Accelerated Infliximab Infusion Safety and Tolerability Is Non-inferior to Standard Infusion Protocol in Inflammatory Bowel Disease Patients: A Randomized Controlled Study;Crohn's & Colitis 360;2023-05-03

2. Systematic Literature Review of Real-World Evidence on Dose Escalation and Treatment Switching in Ulcerative Colitis;ClinicoEconomics and Outcomes Research;2023-02

3. Systematic Review and Meta-analysis: Loss of Response and Need for Dose Escalation of Infliximab and Adalimumab in Ulcerative Colitis;Inflammatory Bowel Diseases;2022-11-01

4. Frequency and Effectiveness of Empirical Anti-TNF Dose Intensification in Inflammatory Bowel Disease: Systematic Review with Meta-Analysis;Journal of Clinical Medicine;2021-05-14

5. Optimizing biologic therapy in inflammatory bowel disease: a Delphi consensus in the United Arab Emirates;Therapeutic Advances in Gastroenterology;2021-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3